BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7012466)

  • 1. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions.
    Lipson DP; Yesalis CE; Kohout FJ; Norwood GJ
    Med Care; 1981 Mar; 19(3):342-53. PubMed ID: 7012466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capitation payment for pharmacy services: impact on generic substitution.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Fisher WP; Burmeister LF
    Med Care; 1980 Aug; 18(8):816-28. PubMed ID: 6997648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
    Cirn JT
    Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: I. Prescription quantity and dose analysis.
    Helling DK; Yesalis CE; Norwood GJ; Burmeister LF; Lipson DP; Fisher WP; Jones ME
    Drug Intell Clin Pharm; 1981; 15(7-8):581-9. PubMed ID: 7018872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preimplementation assessment of a capitation reimbursement system using simulation.
    Standridge CR; Fisher WP; Tsai J
    J Med Syst; 1983 Feb; 7(1):43-59. PubMed ID: 6345708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
    Yesalis CE; Lipson DP; Norwood GJ; Helling DK; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):737-45. PubMed ID: 6381921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capitation payment for pharmacy services. II. Impact on costs.
    Yesalis CE; Norwood GJ; Helling DK; Lipson DP; Mahrenholz RJ; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):746-54. PubMed ID: 6381922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among prescription payment methods and interactions between community pharmacists and prescribers.
    Raisch DW
    Ann Pharmacother; 1992; 26(7-8):902-6. PubMed ID: 1504395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and costs under the Iowa capitation drug program.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Burmeister LF; Fisher WP
    Health Care Financ Rev; 1981 Sep; 3(1):127-36. PubMed ID: 10309472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of prepayment on Medicaid drug costs.
    Yesalls CE; Norwood GJ; Lipson DP
    Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to office-based physicians under capitation reimbursement and Medicaid case management. Findings from the Children's Medicaid Program.
    Hohlen MM; Manheim LM; Fleming GV; Davidson SM; Yudkowsky BK; Werner SM; Wheatley GM
    Med Care; 1990 Jan; 28(1):59-68. PubMed ID: 2404168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capitation for pharmacy services: rationale, findings, and future plans.
    Lipson DP; Yesalis CE; Norwood GJ
    Med Mark Media; 1980 Oct; 15(10):25-32. PubMed ID: 10249119
    [No Abstract]   [Full Text] [Related]  

  • 20. Reimbursement for nondispensing functions: today's innovation is tomorrow's tradition.
    Miller JW
    Contemp Pharm Pract; 1979; 2(2):95-8. PubMed ID: 10297463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.